Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Deucravacitinib (Primary) ; Rosuvastatin
- Indications Autoimmune disorders
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 13 Apr 2017 Status changed from recruiting to completed.
- 09 Feb 2017 New trial record